Cel-Sci
CVM
$1.72
Share price
5.52%
Change (1 day)
-31.20%
Change (1 year)
Categories
Cel-Sci (CVM) - Net assets
Net assets on the balance sheet as of December 2023 : $12.65 M
According to Cel-Sci
's latest financial reports the company has $12.65 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Cel-Sci - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-09-30 | $13.21 M | -58.91% |
| 2022-09-30 | $32.16 M | -43.11% |
| 2021-09-30 | $56.53 M | 186.59% |
| 2020-09-30 | $19.72 M | 284.26% |
| 2019-09-30 | $5.13 M | 560344% |
| 2018-09-30 | $0 M | -100.03% |
| 2017-09-30 | $-3.34 M | 391.3% |
| 2016-09-30 | $-0.68 M | -85.74% |
| 2015-09-30 | $-4.77 M | -145.6% |
| 2014-09-30 | $10.44 M | 55.87% |
| 2013-09-30 | $6.7 M | -4.66% |
| 2012-09-30 | $7.02 M | -22.6% |
| 2011-09-30 | $9.07 M | -67.41% |
| 2010-09-30 | $27.85 M | 215.08% |
| 2009-09-30 | $8.84 M | -18.41% |
| 2008-09-30 | $10.83 M | -26.14% |
| 2007-09-30 | $14.67 M | -1676.41% |
| 2006-09-30 | $-0.94 M | -144.21% |
| 2005-09-30 | $2.1 M | -48.94% |
| 2004-09-30 | $4.12 M | 236.49% |
| 2003-09-30 | $1.22 M | 15.34% |
| 2002-09-30 | $1.06 M | -73.45% |
| 2001-09-30 | $4 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 553,404.66% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 49,163.65% | 🇺🇸 USA |
 Xencor XNCR | $0.66 B | 5,189.46% | 🇺🇸 USA |
 Curis CRIS | $19.67 M | 55.49% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 64,135.63% | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | -$0.46 B | -3,700.93% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.64 B | 5,032.68% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $2.23 M | -82.35% | 🇺🇸 USA |